Nucleolin Antibody (NCL/7339) [DyLight 350]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-20817UV
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
Immunohistochemistry-Paraffin
Label
DyLight 350 (Excitation = 353 nm, Emission = 432 nm)
Antibody Source
Monoclonal Mouse IgG1 kappa Clone # NCL/7339
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for Nucleolin Antibody (NCL/7339) [DyLight 350]
Immunogen
Recombinant full-length human Nucleolin protein
Reactivity Notes
Does not react with mouse, cat, cow, dog or horse.
Localization
Nucleoli.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1 kappa
Applications for Nucleolin Antibody (NCL/7339) [DyLight 350]
Application
Recommended Usage
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Nucleolin
Alternate Names
C23, FLJ45706, FLJ59041, nucleolin, Protein C23
Gene Symbol
NCL
Additional Nucleolin Products
Product Documents for Nucleolin Antibody (NCL/7339) [DyLight 350]
Product Specific Notices for Nucleolin Antibody (NCL/7339) [DyLight 350]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...